# OnCo record newlink-genetics (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/newlink-genetics/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "newlink-genetics" ;
  schema:name "NewLink Genetics (now Lumos Pharma)"@en ;
  schema:alternateName "Lumos Pharma"@en ;
  schema:description "The Iowa biotech that ran the largest pancreatic cancer vaccine trial, IMPRESS, and the IDO inhibitor indoximod programme; it merged into Lumos Pharma in 2020."@en ;
  schema:url <https://onco.cc/companies/newlink-genetics/>, <https://www.lumos-pharma.com> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:citation <https://en.wikipedia.org/wiki/NewLink_Genetics> ;
  schema:addressCountry "US" ;
  onco:cancers <https://onco.cc/cancers/pancreatic/> ;
  onco:drugs <https://onco.cc/drugs/algenpantucel-l/> .